NASDAQ:BBH VanEck Biotech ETF (BBH) Price, Holdings, & News $179.06 +1.29 (+0.73%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$178.83▼$179.8350-Day Range$162.36▼$179.1952-Week Range$142.51▼$180.90Volume4,234 shsAverage Volume7,676 shsMarket Capitalization$460.18 millionAssets Under Management$457.80 millionDividend Yield0.40%Net Expense Ratio0.35% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends Get VanEck Biotech ETF alerts: Email Address About VanEck Biotech ETF (NASDAQ:BBH)The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.Read More BBH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BBH ETF News HeadlinesMarch 29, 2024 | benzinga.comFuture-Proof Your Portfolio: Learn From ETF Expert Jan Van Eck In NYCMarch 22, 2024 | seekingalpha.comGNOM: Genomics Still Waiting For Its 'ChatGPT' MomentJuly 26, 2024 | American Hartford Gold Group (Ad)Dave Ramsey Makes Big Mistake Live On AirDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.January 30, 2024 | msn.comVanEck CEO Says Cryptos Deserve A Place In Everyone's PortfolioDecember 19, 2023 | msn.comVanEck Vectors Biotech ETF declares annual distribution of $0.7127December 9, 2023 | seekingalpha.comBBH: A Solid Way To Play A Comeback In BiotechOctober 24, 2023 | investing.comBBH ETF Stock Price HistorySeptember 13, 2023 | msn.comBBH: Our Favorite Biotech ETF Can Keep OutperformingJuly 26, 2024 | WealthPress (Ad)This TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.August 7, 2023 | morningstar.comVanEck ETFsSee More Headlines Receive BBH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VanEck Biotech ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerVan Eck Fund NameVanEck Biotech ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:BBH Inception Date12/20/2011 Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkMarket Vectors US Listed Biotech 25 Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionGlobal Number of Holdings27 Fund Statistics Assets Under Management$457.80 million Average Daily Volume$6,486.90 Discount/Premium-0.26% Administrator, Advisor and Custodian AdministratorVan Eck Associates Corporation AdvisorVan Eck Associates Corporation CustodianState Street Bank and Trust Company DistributorVan Eck Securities Corporation Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume8 Put Options2 Call Options6 Short Interest3,800 shs Miscellaneous Outstanding Shares2,570,000Beta0.74 Creation Unit50,000 Creation Fee$500.00 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Ad DTIHow a $0.25 cent option contract makes my top traders feelIf you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…Click now to see for yourself what $0.25 Cent Trades is all about VanEck Biotech ETF ExpensesTypeBBHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.35%0.56%0.54%0.48%0.51%Other Expenses0.00%0.33%0.50%0.39%0.54%Total Expense0.35%0.70%0.70%0.61%0.71%Fee Waiver0.00%-0.45%-0.54%-0.32%-0.59%Net Expense0.35%0.61%0.60%0.54%0.59% VanEck Biotech ETF (BBH) Holdings & ExposureTop 10 BBH HoldingsAmgen(NASDAQ:AMGN)Holding Weight: 15.70%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 9.97%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 8.07%Gilead Sciences(NASDAQ:GILD)Holding Weight: 7.46%argenx(NASDAQ:ARGX)Holding Weight: 5.26%IQVIA(NYSE:IQV)Holding Weight: 4.95%ICON Public(NASDAQ:ICLR)Holding Weight: 4.42%Biogen(NASDAQ:BIIB)Holding Weight: 4.21%Moderna(NASDAQ:MRNA)Holding Weight: 3.95%Illumina(NASDAQ:ILMN)Holding Weight: 3.84%BBH Sector ExposureBBH Industry ExposureFull Holdings Details Similar ETFsVanEck Pharmaceutical ETFNASDAQ:PPHInvesco S&P SmallCap Health Care ETFNASDAQ:PSCHInvesco Dorsey Wright Healthcare Momentum ETFNASDAQ:PTHProShares Ultra Nasdaq BiotechnologyNASDAQ:BIBInvesco Nasdaq Biotechnology ETFNASDAQ:IBBQInstitutional OwnershipHyman Charles DBought 1,200 shares on 7/26/2024Ownership: 0.047%Red Lighthouse Investment Management LLCBought 300 shares on 7/24/2024Ownership: 0.012%Consolidated Investment Group LLCSold 13,500 shares on 7/22/2024Ownership: 0.630%Pacific Sun Financial CorpSold 150 shares on 7/19/2024Ownership: 0.226%Wealth Enhancement Advisory Services LLCSold 161 shares on 7/16/2024Ownership: 0.089%View All Institutional Transactions BBH ETF - Frequently Asked Questions How have BBH shares performed this year? VanEck Biotech ETF's stock was trading at $165.31 at the beginning of 2024. Since then, BBH stock has increased by 8.3% and is now trading at $179.06. View the best growth stocks for 2024 here. Who are VanEck Biotech ETF's major shareholders? Top institutional shareholders of VanEck Biotech ETF include Consolidated Investment Group LLC (0.63%), Pacific Sun Financial Corp (0.23%), Wealth Enhancement Advisory Services LLC (0.09%) and Hyman Charles D (0.05%). How do I buy shares of VanEck Biotech ETF? Shares of BBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of VanEck Biotech ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that VanEck Biotech ETF investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Intel (INTC), Micron Technology (MU) and Cidara Therapeutics (CDTX). This page (NASDAQ:BBH) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredWhy is NVDA stumbling?July is historically the best month of the year for U.S. stocks. So why are everyone’s favorite tech stocks...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
